Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > CD59(Gene name) > Human
  • Add your favorite
  • CD59 (Gene name),
  • CD59 glycoprotein (Protein name ),  CD59_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Citations  (1)
  • |
  • Feedback
  • Gene name:
    CD59(MIC11;MIN1;MIN2;MIN3;MSK21);
    Protein name:
    CD59 glycoprotein;
    Alternative:
    20 kDa homologous restriction factor(HRF-20;HRF20);1F5 antigen;MEM43 antigen;MAC-inhibitory protein(MAC-IP);Membrane inhibitor of reactive lysis(MIRL);Membrane attack complex inhibition factor(MACIF);Protectin;
    CD:
    CD59;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with T-cell surface antigen CD2.
    Function:
    The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit MAC assembly on cell membranes.
    Subcellular Location:
    Cell membrane Lipid-anchor GPI-anchor Secreted Soluble form found in a number of tissues.
    Protein Attributes:
    Sequence length:
    128
    Sequence:
    50:
    MGIQGGSVLF | GLLLVLAVFC | HSGHSLQCYN | CPNPTADCKT | AVNCSSDFDA | 
    100:
    CLITKAGLQV | YNKCWKFEHC | NFNDVTTRLR | ENELTYYCCK | KDLCNFNEQL | 
    128:
    ENGGTSLSEK | TVLLLVTPFL | AAAWSLHP
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    KEGG:
    String:
    SMR:
    MIM:
    UniGene:
    Pfam:
    Uniprot:
     
    FOR
    ELISA Kit for Human CD59 glycoprotein
    Cat.:
    E2116h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human CD59 glycoprotein
    Cat.:
    E2116r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human CD59 glycoprotein
    Cat.:
    E2116p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    ELISA Kit for Human CD59 glycoprotein
    MSDS:
    Please sign in first.
    CLIA Kit for Human CD59 glycoprotein
    Cat.:
    U2116p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human CD59 glycoprotein
    Cat.:
    U2116r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human CD59 glycoprotein
    MSDS:
    Please sign in first.
    CLIA Kit for Human CD59 glycoprotein
    Cat.:
    U2116h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human CD59 glycoprotein
    Cat.:
    P2116Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human CD59 glycoprotein
    Polyclonal Antibody for Human CD59 glycoprotein
    Cat.:
    P2116Rb-r
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human CD59 glycoprotein
    Monoclonal Antibody for Human CD59 glycoprotein
    Monoclonal Antibody for Human CD59 glycoprotein
    Monoclonal Antibody for Human CD59 glycoprotein
    Monoclonal Antibody for Human CD59 glycoprotein
    Protein for Human CD59 glycoprotein
    Protein for Human CD59 glycoprotein
    Protein for Human CD59 glycoprotein
    Protein for Human CD59 glycoprotein

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells."
      Davies A. , Simmons D.L. , Hale G. , Harrison R.A. , Tighe H. , Lachmann P.J. , Waldmann H.
      J. Exp. Med.170:637-654(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA]
      tissue: T-cell.
    2. 2.
      "The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility."
      Philbrick W.M. , Palfree R.G.E. , Roger G.E. , Maher S.E. , Bridgett M.M. , Sirlin S. , Bothwell A.L.M.
      Eur. J. Immunol.20:87-92(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA]
    3. 3.
      "20 KDa homologous restriction factor of complement resembles T cell activating protein."
      Okada H. , Nagami Y. , Takahashi K. , Okada N. , Hideshima T. , Takizawa H. , Kondo J.
      Biochem. Biophys. Res. Commun.162:1553-1559(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA]
    4. 4.
      "Molecular cloning and characterization of MACIF, an inhibitor of membrane channel formation of complement."
      Sugita Y. , Tobe T. , Oda E. , Tomita M. , Yasukawa K. , Yamaji N. , Takemoto T. , Furuichi K. , Takayama M. , Yano S.
      J. Biochem.106:555-557(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA]
    5. 5.
      "Isolation and expression of the full-length cDNA encoding CD59 antigen of human lymphocytes."
      Sawada R. , Ohashi K. , Anaguchi H. , Okazaki H. , Hattori M. , Minato N. , Naruto M.
      DNA Cell Biol.9:213-220(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA]
    6. 6.
      "Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein."
      Petranka J.G. , Fleenor D.E. , Sykes K. , Kaufman R.E. , Rosse W.F.
      Proc. Natl. Acad. Sci. U.S.A.89:7876-7879(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    7. 7.
      "Gene structure of human CD59 and demonstration that discrete mRNAs are generated by alternative polyadenylation."
      Tone M. , Walsh L.A. , Waldmann H.
      J. Mol. Biol.227:971-976(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
      tissue: Blood.
    8. 8.
      "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."
      Kalnine N. , Chen X. , Rolfs A. , Halleck A. , Hines L. , Eisenstein S. , Koundinya M. , Raphael J. , Moreira D. , Kelley T. , LaBaer J. , Lin Y. , Phelan M. , Farmer A.
      Submitted (2003-05) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
    9. 9.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
      tissue: Colon.
    10. 10.
      "Complementary DNA sequence and deduced peptide sequence for CD59/MEM-43 antigen, the human homologue of murine lymphocyte antigen Ly-6C."
      Sawada R. , Ohashi K. , Okano K. , Hattori M. , Minato N. , Naruto M.
      Nucleic Acids Res.17:6728-6728(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 27-128
    11. 11.
      "Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis."
      Meri S. , Lehto T. , Sutton C.W. , Tyynelaa J. , Baumann M.
      Biochem. J.316:923-935(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE;IDENTIFICATION BY MASS SPECTROMETRY;GLYCOSYLATION AT ASN-43;STRUCTURE OF CARBOHYDRATES
    12. 12.
      "Determination of carboxyl-terminal residue and disulfide bonds of MACIF (CD59), a glycosyl-phosphatidylinositol-anchored membrane protein."
      Sugita Y. , Nakano Y. , Oda E. , Noda K. , Tobe T. , Miura N.H. , Tomita M.
      J. Biochem.114:473-477(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GPI-ANCHOR AT ASN-102;DISULFIDE BONDS
    13. 13.
      "The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the ''b'' domain of C9."
      Ninomiya H. , Sims P.J.
      J. Biol. Chem.267:13675-13680(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH C8 AND C9
    14. 14.
      "Mapping the regions of the complement inhibitor CD59 responsible for its species selective activity."
      Yu J. , Dong S. , Rushmere N.K. , Morgan B.P. , Abagyan R. , Tomlinson S.
      Biochemistry36:9423-9428(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION OF COMPLEMENT INHIBITORY DOMAIN
    15. 15.
      "Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59."
      Bodian D.L. , Davis S.J. , Morgan B.P. , Rushmere N.K.
      J. Exp. Med.185:507-516(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: MUTAGENESIS
    16. 16.
      "The glycosylation of the complement regulatory protein, human erythrocyte CD59."
      Rudd P.M. , Morgan B.P. , Wormald M.R. , Harvey D.J. , van den Berg C.W. , Davis S.J. , Ferguson M.A. , Dwek R.A.
      J. Biol. Chem.272:7229-7244(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE OF CARBOHYDRATES;STRUCTURE OF THE GPI-ANCHOR;PROTEIN SEQUENCE OF N-TERMINUS
    17. 17.
      "Molecular basis for a link between complement and the vascular complications of diabetes."
      Acosta J. , Hettinga J. , Flueckiger R. , Krumrei N. , Goldfine A. , Angarita L. , Halperin J.
      Proc. Natl. Acad. Sci. U.S.A.97:5450-5455(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INHIBITION BY GLYCATION;GLYCATION AT LYS-66 AND HIS-69;MUTAGENESIS OF LYS-66 AND HIS-69
    18. 18.
      "Proteomic analysis of glycosylphosphatidylinositol-anchored membrane proteins."
      Elortza F. , Nuehse T.S. , Foster L.J. , Stensballe A. , Peck S.C. , Jensen O.N.
      Mol. Cell. Proteomics2:1261-1270(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GPI-ANCHOR [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    19. 19.
      "Modification-specific proteomics of plasma membrane proteins: identification and characterization of glycosylphosphatidylinositol-anchored proteins released upon phospholipase D treatment."
      Elortza F. , Mohammed S. , Bunkenborg J. , Foster L.J. , Nuehse T.S. , Brodbeck U. , Peck S.C. , Jensen O.N.
      J. Proteome Res.5:935-943(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GPI-ANCHOR [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    20. 20.
      "Computational approach for identification and characterization of GPI-anchored peptides in proteomics experiments."
      Omaetxebarria M.J. , Elortza F. , Rodriguez-Suarez E. , Aloria K. , Arizmendi J.M. , Jensen O.N. , Matthiesen R.
      Proteomics7:1951-1960(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GPI-ANCHOR AT ASN-102;IDENTIFICATION BY MASS SPECTROMETRY
    21. 21.
      "Identification of N-linked glycoproteins in human milk by hydrophilic interaction liquid chromatography and mass spectrometry."
      Picariello G. , Ferranti P. , Mamone G. , Roepstorff P. , Addeo F.
      Proteomics8:3833-3847(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-43
      tissue: Milk.
    22. 22.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    23. 23.
      "Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins."
      Kieffer B. , Driscoll P.C. , Campbell I.D. , Willis A.C. , van der Merwe P.A. , Davis S.J.
      Biochemistry33:4471-4482(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 26-95
    24. 24.
      "Structure of a soluble, glycosylated form of the human complement regulatory protein CD59."
      Fletcher C.M. , Harrison R.A. , Lachmann P.J. , Neuhaus D.
      Structure2:185-199(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 26-102
      tissue: Urine.
    25. 25.
      "Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene."
      Motoyama N. , Okada N. , Yamashina M. , Okada H.
      Eur. J. Immunol.22:2669-2673(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN HACD59
    26. 26.
      "CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy."
      Nevo Y. , Ben-Zeev B. , Tabib A. , Straussberg R. , Anikster Y. , Shorer Z. , Fattal-Valevski A. , Ta-Shma A. , Aharoni S. , Rabie M. , Zenvirt S. , Goldshmidt H. , Fellig Y. , Shaag A. , Mevorach D. , Elpeleg O.
      Blood121:129-135(2013) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HACD59 TYR-89
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Alpha Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter